Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy
Identifieur interne : 001685 ( Main/Exploration ); précédent : 001684; suivant : 001686Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy
Auteurs : S. Balachandar [Inde] ; A. Katyal [Inde]Source :
- European Journal of Clinical Microbiology & Infectious Diseases [ 0934-9723 ] ; 2011-04-01.
Abstract
Abstract: Cerebral malaria (CM) is a global life-threatening complication of Plasmodium infection and represents a major cause of morbidity and mortality among severe forms of malaria. Despite developing knowledge in understanding mechanisms of pathogenesis, the current anti-malarial agents are not sufficient due to drug resistance and various adverse effects. Therefore, there is an urgent need for the novel target and additional therapy. Recently, peroxisome proliferator-activated receptor (PPAR) a nuclear receptors (NR) and agonists of its isoforms (PPARγ, PPARα and PPARβ/δ) have been demonstrated to exhibit anti-inflammatory and immunomodulatory properties, which are driven to a new approach of research on inflammatory diseases. Although many studies on PPARs have confirmed their diverse biological role, there is a lack of knowledge of its therapeutic use in CM. The major objective of this review is to explore the possible experimental studies to link these two areas of research. We focus on the data describing the beneficial effects of this receptor in inflammation, which is observed as a basic pathology in CM. In conclusion, PPARs could be a novel target in treating inflammatory diseases, and continued work with the available and additional agonists screened from various sources may result in a potential new treatment for CM.
Url:
DOI: 10.1007/s10096-010-1122-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C02
- to stream Istex, to step Curation: 000C02
- to stream Istex, to step Checkpoint: 000630
- to stream Main, to step Merge: 001688
- to stream Main, to step Curation: 001685
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy</title><author><name sortKey="Balachandar, S" sort="Balachandar, S" uniqKey="Balachandar S" first="S." last="Balachandar">S. Balachandar</name></author><author><name sortKey="Katyal, A" sort="Katyal, A" uniqKey="Katyal A" first="A." last="Katyal">A. Katyal</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BE10848F6186A8E5EFBDADB80BB6F95BF6E134F6</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1007/s10096-010-1122-9</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-ZGXPGG8W-1/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000C02</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C02</idno><idno type="wicri:Area/Istex/Curation">000C02</idno><idno type="wicri:Area/Istex/Checkpoint">000630</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000630</idno><idno type="wicri:doubleKey">0934-9723:2010:Balachandar S:peroxisome:proliferator:activating</idno><idno type="wicri:Area/Main/Merge">001688</idno><idno type="wicri:Area/Main/Curation">001685</idno><idno type="wicri:Area/Main/Exploration">001685</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy</title><author><name sortKey="Balachandar, S" sort="Balachandar, S" uniqKey="Balachandar S" first="S." last="Balachandar">S. Balachandar</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Dr. B. R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi, 110007, Delhi</wicri:regionArea><wicri:noRegion>Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Katyal, A" sort="Katyal, A" uniqKey="Katyal A" first="A." last="Katyal">A. Katyal</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Dr. B. R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi, 110007, Delhi</wicri:regionArea><wicri:noRegion>Delhi</wicri:noRegion></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Clinical Microbiology & Infectious Diseases</title><title level="j" type="abbrev">Eur J Clin Microbiol Infect Dis</title><idno type="ISSN">0934-9723</idno><idno type="eISSN">1435-4373</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2011-04-01">2011-04-01</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="483">483</biblScope><biblScope unit="page" to="498">498</biblScope></imprint><idno type="ISSN">0934-9723</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0934-9723</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Cerebral malaria (CM) is a global life-threatening complication of Plasmodium infection and represents a major cause of morbidity and mortality among severe forms of malaria. Despite developing knowledge in understanding mechanisms of pathogenesis, the current anti-malarial agents are not sufficient due to drug resistance and various adverse effects. Therefore, there is an urgent need for the novel target and additional therapy. Recently, peroxisome proliferator-activated receptor (PPAR) a nuclear receptors (NR) and agonists of its isoforms (PPARγ, PPARα and PPARβ/δ) have been demonstrated to exhibit anti-inflammatory and immunomodulatory properties, which are driven to a new approach of research on inflammatory diseases. Although many studies on PPARs have confirmed their diverse biological role, there is a lack of knowledge of its therapeutic use in CM. The major objective of this review is to explore the possible experimental studies to link these two areas of research. We focus on the data describing the beneficial effects of this receptor in inflammation, which is observed as a basic pathology in CM. In conclusion, PPARs could be a novel target in treating inflammatory diseases, and continued work with the available and additional agonists screened from various sources may result in a potential new treatment for CM.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Balachandar, S" sort="Balachandar, S" uniqKey="Balachandar S" first="S." last="Balachandar">S. Balachandar</name></noRegion><name sortKey="Katyal, A" sort="Katyal, A" uniqKey="Katyal A" first="A." last="Katyal">A. Katyal</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001685 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001685 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:BE10848F6186A8E5EFBDADB80BB6F95BF6E134F6
|texte= Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy
}}
| This area was generated with Dilib version V0.6.33. |  |